These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27822568)

  • 21. Statistical considerations in the intent-to-treat principle.
    Lachin JM
    Control Clin Trials; 2000 Jun; 21(3):167-89. PubMed ID: 10822117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are current standards of reporting quality for clinical trials sufficient in addressing important sources of bias?
    Mills EJ; Ayers D; Chou R; Thorlund K
    Contemp Clin Trials; 2015 Nov; 45(Pt A):2-7. PubMed ID: 26232560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of reporting of randomized trials as a measure of methodologic quality.
    Huwiler-Müntener K; Jüni P; Junker C; Egger M
    JAMA; 2002 Jun; 287(21):2801-4. PubMed ID: 12038917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blinding in randomised trials: hiding who got what.
    Schulz KF; Grimes DA
    Lancet; 2002 Feb; 359(9307):696-700. PubMed ID: 11879884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reporting of outcomes in orthopaedic randomized trials: does blinding of outcome assessors matter?
    Poolman RW; Struijs PA; Krips R; Sierevelt IN; Marti RK; Farrokhyar F; Bhandari M
    J Bone Joint Surg Am; 2007 Mar; 89(3):550-8. PubMed ID: 17332104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010.
    Baethge C; Assall OP; Baldessarini RJ
    Psychother Psychosom; 2013; 82(3):152-60. PubMed ID: 23548796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deliberate ignorance: a systematic review of blinding in nursing clinical trials.
    Polit DF; Gillespie BM; Griffin R
    Nurs Res; 2011; 60(1):9-16. PubMed ID: 21127453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blinding in randomized controlled trials in general and abdominal surgery: protocol for a systematic review and empirical study.
    Probst P; Grummich K; Heger P; Zaschke S; Knebel P; Ulrich A; Büchler MW; Diener MK
    Syst Rev; 2016 Mar; 5():48. PubMed ID: 27012940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
    Fergusson D; Glass KC; Waring D; Shapiro S
    BMJ; 2004 Feb; 328(7437):432. PubMed ID: 14761905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expert witness blinding strategies to mitigate bias in radiology malpractice cases: a comprehensive review of the literature.
    Durand DJ; Robertson CT; Agarwal G; Duszak R; Krupinski EA; Itri JN; Fotenos A; Savoie B; Ding A; Lewin JS
    J Am Coll Radiol; 2014 Sep; 11(9):868-73. PubMed ID: 25041992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample size calculations for blinding assessment.
    Landsman V; Fillery M; Vernon H; Bang H
    J Biopharm Stat; 2018; 28(5):857-869. PubMed ID: 29157126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing like with like: some historical milestones in the evolution of methods to create unbiased comparison groups in therapeutic experiments.
    Chalmers I
    Int J Epidemiol; 2001 Oct; 30(5):1156-64. PubMed ID: 11689539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical aspects of randomization and blinding in randomized clinical trials.
    Bridgman S; Engebretsen L; Dainty K; Kirkley A; Maffulli N;
    Arthroscopy; 2003 Nov; 19(9):1000-6. PubMed ID: 14608321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of bias assessments for blinding of participants and personnel in Cochrane reviews were frequently inadequate.
    Barcot O; Boric M; Dosenovic S; Poklepovic Pericic T; Cavar M; Puljak L
    J Clin Epidemiol; 2019 Sep; 113():104-113. PubMed ID: 31132470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lay public's understanding of equipoise and randomisation in randomised controlled trials.
    Robinson EJ; Kerr CE; Stevens AJ; Lilford RJ; Braunholtz DA; Edwards SJ; Beck SR; Rowley MG
    Health Technol Assess; 2005 Mar; 9(8):1-192, iii-iv. PubMed ID: 15763039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eliminating bias in randomized controlled trials: importance of allocation concealment and masking.
    Viera AJ; Bangdiwala SI
    Fam Med; 2007 Feb; 39(2):132-7. PubMed ID: 17273956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blinding in Surgical Randomized Clinical Trials in 2015.
    Speich B
    Ann Surg; 2017 Jul; 266(1):21-22. PubMed ID: 28350566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.
    Buchbinder R; Golmohammadi K; Johnston RV; Owen RJ; Homik J; Jones A; Dhillon SS; Kallmes DF; Lambert RG
    Cochrane Database Syst Rev; 2015 Apr; (4):CD006349. PubMed ID: 25923524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Don't Be Blinded by the Blinding.
    Betensky RA
    NEJM Evid; 2022 Mar; 1(3):EVIDe2100063. PubMed ID: 38319191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Early Use of Blinding in Therapeutic Clinical Research of Neurological Disorders.
    Jensen MB; Janik EL; Waclawik AJ
    J Neurol Res Ther; 2016; 1(2):4-16. PubMed ID: 27617324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.